Osaic Holdings’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.3K Sell
4,097
-4,331
-51% -$16.5K ﹤0.01% 6078
2025
Q4
$29.2K Buy
8,428
+1,478
+21% +$6.57K ﹤0.01% 5603
2025
Q3
$37.4K Buy
6,950
+6,822
+5,330% +$27.7K ﹤0.01% 5501
2025
Q2
$315 Sell
128
-36
-22% -$55 ﹤0.01% 7444
2025
Q1
$324 Sell
164
-224
-58% -$571 ﹤0.01% 7088
2024
Q4
$1.13K Sell
388
-9,513
-96% -$33.4K ﹤0.01% 6806
2024
Q3
$38.3K Sell
9,901
-800
-7% -$3.71K ﹤0.01% 4933
2024
Q2
$55K Sell
10,701
-908
-8% -$5.5K ﹤0.01% 4607
2024
Q1
$81.3K Sell
11,609
-1,961
-14% -$14.9K ﹤0.01% 4389
2023
Q4
$120K Buy
13,570
+5,608
+70% +$43.2K ﹤0.01% 4300
2023
Q3
$75.9K Buy
7,962
+1,559
+24% +$20.3K ﹤0.01% 4707
2023
Q2
$93.8K Sell
6,403
-28
-0.4% -$391 ﹤0.01% 4487
2023
Q1
$79.1K Buy
6,431
+402
+7% +$6.55K ﹤0.01% 4629
2022
Q4
$112K Buy
+6,029
New +$109K ﹤0.01% 4335

Other funds holding PRME